VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $717,000 | +45.1% | 34,500 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $494,000 | -17.3% | 34,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $597,000 | +56.7% | 34,500 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $381,000 | -24.0% | 34,500 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $501,000 | -94.1% | 34,500 | -90.0% | 0.00% | -94.3% |
Q3 2016 | $8,503,000 | -24.3% | 346,336 | -37.9% | 0.05% | -25.4% |
Q2 2016 | $11,237,000 | -25.2% | 557,933 | -2.3% | 0.07% | -26.0% |
Q1 2016 | $15,025,000 | -51.0% | 571,305 | +89.6% | 0.10% | -52.7% |
Q4 2015 | $30,635,000 | +1.3% | 301,374 | +77.8% | 0.20% | -2.9% |
Q3 2015 | $30,243,000 | +4.2% | 169,542 | +29.8% | 0.21% | +8.3% |
Q2 2015 | $29,017,000 | -18.6% | 130,617 | -27.2% | 0.19% | -21.9% |
Q1 2015 | $35,653,000 | +45.3% | 179,505 | +4.7% | 0.25% | +41.1% |
Q4 2014 | $24,545,000 | +8.1% | 171,513 | -0.9% | 0.18% | 0.0% |
Q3 2014 | $22,699,000 | +21.7% | 173,012 | +17.0% | 0.18% | +19.0% |
Q2 2014 | $18,649,000 | +381.6% | 147,867 | +403.5% | 0.15% | +345.5% |
Q1 2014 | $3,872,000 | +605.3% | 29,370 | +528.2% | 0.03% | +560.0% |
Q4 2013 | $549,000 | +43.3% | 4,675 | +27.2% | 0.01% | +25.0% |
Q3 2013 | $383,000 | +36.8% | 3,675 | +13.1% | 0.00% | +33.3% |
Q2 2013 | $280,000 | – | 3,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |